Institution
Addenbrooke's Hospital
- 130running trials
- 38closed trials
- 39,413publications (OpenAlex)
Running trials
Not yet recruiting
Recruiting
Recruiting
Recruiting
A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Not yet recruiting
DECODE - Haemodynamic Effects Of Semaglutide and Tirzepatide - a Series of Pilot Studies
Recruiting
Recruiting
Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN)
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Recruiting
Active, not recruiting
Recruiting
Obe-cel in Refractory Progressive Forms of Multiple Sclerosis
Recruiting
Investigating Idetrexed and Olaparib in Patients With Ovarian Cancer
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
ARMSTRONG - Air entRainMent vS sTandard tReatment in nOn-expandable luNG
Recruiting
Recruiting
Active, not recruiting
Pembrolizumab With Olaparib as Combined Therapy in Metastatic Pancreatic Cancer
Recruiting
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN)
Active, not recruiting
A Phase 1b Trial to Evaluate Safety of MB097 in Combination With Pembrolizumab in Melanoma Patients
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Low-Dose IL-2 For The Reduction Of Vascular Inflammation In ACS -Clinical Outcomes & Follow-up Study
Active, not recruiting
Showing 50 of 130.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Childhood cancers12 recruiting
- Lung cancer10 recruiting
- Prostate cancer9 recruiting
- Colorectal cancer6 recruiting
- Melanoma6 recruiting
- Multiple myeloma6 recruiting
- Ovarian cancer6 recruiting
- Pancreatic cancer5 recruiting
- Bladder cancer4 recruiting
- High blood pressure4 recruiting
- Kidney cancer4 recruiting
- Liver and biliary tract cancer4 recruiting
- Gastric and oesophageal cancer3 recruiting
- Head and neck cancer3 recruiting
- Sarcoma3 recruiting
- Stroke3 recruiting
- Thyroid cancer3 recruiting
- Cervical cancer2 recruiting
- Coronary artery disease2 recruiting
- Crohn's disease2 recruiting
- Endometrial cancer2 recruiting
- Fatty liver disease (MASLD/MASH)2 recruiting
- Liver cirrhosis2 recruiting
- Lupus (SLE)2 recruiting
- Mesothelioma2 recruiting
- Myeloproliferative neoplasms2 recruiting
- Neuroblastoma2 recruiting
- Neuroendocrine tumours2 recruiting
- Obesity2 recruiting
- Type 1 diabetes2 recruiting
- Type 2 diabetes2 recruiting
- Ulcerative colitis2 recruiting
- Acute lymphoblastic leukaemia1 recruiting
- ANCA-associated vasculitis1 recruiting
- Asthma1 recruiting
- Atrial fibrillation1 recruiting
- Deep vein thrombosis and pulmonary embolism1 recruiting
- Gaucher disease1 recruiting
- Haemophilia1 recruiting
- Metastatic breast cancer1 recruiting
- Mitochondrial disease1 recruiting
- Multiple sclerosis1 recruiting
- Myelodysplastic syndromes1 recruiting
- Pompe disease1 recruiting
- Sickle cell disease1 recruiting
- Spinal cord injury1 recruiting
- Spinal muscular atrophy1 recruiting
Closed trials
Completed
Completed
Completed
Terminated
Completed
Completed
Completed
Completed
ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2
Completed
A Study to Evaluate the Safety of mRNA-0184 in Participants With Heart Failure
Terminated
Completed
Terminated
Completed
Setmelanotide in Pediatric Participants With Rare Genetic Diseases of Obesity
Completed
Completed
Completed
Completed
Completed
Terminated
Terminated
Completed
Completed
AURORAX-0087A: GAG Scores for Surveillance of Recurrence in Leibovich Points ≥5 Non-metastatic ccRCC
Completed
Completed
A Heart Disease Study of Semaglutide in Patients With Type 2 Diabetes
Completed
Randomised Study of Oral Azacitidine vs Placebo Maintenance in AML or MDS Patients After Allo-SCT
Completed
BEAT-meso: Bevacizumab and Atezolizumab in Malignant Pleural Mesothelioma
Completed
Completed
Completed
Completed
Study of Ibrutinib and Rituximab in Treatment Naïve Follicular Lymphoma
Completed
Completed
A Study of Avelumab With Axitinib Versus Sunitinib In Advanced Renal Cell Cancer (JAVELIN Renal 101)
Completed
Gene Therapy Study in Severe Haemophilia A Patients (270-201)
Completed
Completed
Registry of Translarna (Ataluren) in Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD)
Completed
Completed
Trial of Haploidentical Stem Cell Transplantation for Haematological Cancers
Completed
Registry name variants (32)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
Addenbrooke's Hospital
Cambridge, Cambridgeshire CB2 0QQ
128 trials
Addenbrooke's Hospital Cambridge
Cambridge, CB2 0QQ
9 trials
Cambridge University - Addenbrooke's Hospital
Cambridge, CB2 0QQ
3 trials
NCT06564142Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN)
NCT06121011A Global Prospective Observational Registry of Patients With Pompe Disease
Contact: For Site
NCT06047171Rescue of Nephrons With ALE.F02 (RENAL-F02)
Contact: Mohamed Benabed
Addenbrooke's Hospital - Cambridge Dialysis Centre
Cambridge, CB5 8PD
1 trial
Addenbrooke's Hospital, Central Pharmacy, Level 1
Cambridge, CB2 0QQ
1 trial
Addenbrooke's Hospital - Dept of Oncology
Cambridge
1 trial
Addenbrooke's Hospital - Haemophilia and Thrombophilia
Cambridge, CB2 0QQ
1 trial
NCT06612268A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
Contact: Novo Nordisk
Addenbrooke's Hospital, Hemophilia and Thrombophilia Center
Cambridge
1 trial
Addenbrooke's Hospital
Cambridge, Cambridgeshire CB2 2QQ
1 trial
Addenbrooke's Hospital in Cambridge (Site 0600)
Cambridge, Cambridgeshire CB2 0QQ
1 trial
Addenbrooke's Hospital - Oncology
Cambridge, Cambridgeshire CB2 0QQ
1 trial
Addenbrooke's Hospital (Site 0747)
Cambridge, Cambridgeshire CB2 2QQ
1 trial
Addenbrooke's Hospital (Site 0915)
Cambridge, Cambridgeshire CB2 2QQ
1 trial
Contact: Study Coordinator
Addenbrooke's Hospital (Site 1004)
Cambridge, Cambridgeshire CB2 2QQ
1 trial
Addenbrooke's Hospital (Site 1309)
Cambridge, Cambridgeshire CB2 2QQ
1 trial
Contact: Study Coordinator
Addenbrooke's Hospital (Site 1407)
Cambridge, Cambridgeshire CB2 0QQ
1 trial
Addenbrooke's Hospital (Site 1426)
Cambridge, Cambridgeshire CB2 2QQ
1 trial
Addenbrooke's Hospital (Site 1525)
Cambridge, Cambridgeshire CB2 0QQ
1 trial
Contact: Study Coordinator
Addenbrooke's Hospital (Site 1605)
Cambridge, Cambridgeshire CB2 2QQ
1 trial
NCT06136624Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
Contact: Study Coordinator
Addenbrooke's Hospital (Site 1610)
Cambridge, Cambridgeshire CB2 2QQ
1 trial
Addenbrooke's Hospital (Site 1800)
Cambridge, Cambridgeshire CB2 2QQ
1 trial
Addenbrooke's Hospital (Site 1902)
Cambridge, Cambridgeshire CB2 2QQ
1 trial
Addenbrooke's Hospital (Site 2005)
Cambridge, Cambridgeshire CB2 2QQ
1 trial
Addenbrooke's Hospital (Site 2200)
Cambridge, Cambridgeshire CB2 0QQ
1 trial
Addenbrooke's Hospital (Site 2203)
Cambridge, Cambridgeshire CB2 2QQ
1 trial
Addenbrooke's Hospital (Site 2400)
Cambridge, Cambridgeshire CB2 2QQ
1 trial
Contact: Study Coordinator
Addenbrooke's Hospital (Site 2808)
Cambridge, Cambridgeshire CB2 2QQ
1 trial
Addenbrooke's Hospital (Site 3217)
Cambridge, Cambridgeshire CB2 2QQ
1 trial
Addenbrooke's Hospital (Site 3303)
Cambridge, Cambridgeshire CB2 2QQ
1 trial
Addenbrooke's Hospital, Wellcome Trust-MRC Institute of Metabolic Science
Cambridge, CB2 0QQ
1 trial
Cambridge Clinical Trials Unit, Addenbrooke's Hospital
Cambridge, CB2 0QQ
1 trial
Department of Clinical Neurosciences, Addenbrooke's Hospital
Cambridge
1 trial
NCT05650229Efficacy of KL1333 in Adult Patients With Primary Mitochondrial Disease
Contact: Rita Horvath, MD (principal investigator)
Conditions
Diseases this institution publishes on or runs trials for.
- ANCA-associated vasculitis8 works · 1 trial
- Pituitary tumours8 works · 0 trials
- Barrett's oesophagus3 works · 0 trials
Institution data: ROR 055vbxf86 (CC0-1.0)Updated 15 Nov 2026